Skip to main content
Figure 3 | Journal of Translational Medicine

Figure 3

From: A novel multiplex assay combining autoantibodies plus PSA has potential implications for classification of prostate cancer from non-malignant cases

Figure 3

Distribution of autoAb in patients with BPH/prostatitis and prostate cancer. Histograms depicting the frequency or number of patients and their specific MFI ratios against NY-ESO-1:1-40 (A), AMACR:341-371 (B), SSX-2,4 (C), p90 autoantigen (D), LEDGF (E), and XAGE-1b (F) in patients with BPH and/or prostatitis (n = 121) and prostate cancer (n = 131). Mean values of MFI ratios from 3 serum dilutions at 1/10, 1/20 and 1/50 were normalized against those obtained from HD (n = 124) to minimize experiment-to-experiment variations.

Back to article page